Twist Bioscience Corp (TWST)
41.86
+0.29
(+0.70%)
USD |
NASDAQ |
Nov 04, 13:08
Twist Bioscience Profit Margin (Quarterly): -105.0% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -105.0% |
| March 31, 2024 | -60.41% |
| December 31, 2023 | -60.15% |
| September 30, 2023 | -69.08% |
| June 30, 2023 | -90.05% |
| March 31, 2023 | -98.30% |
| December 31, 2022 | -77.10% |
| September 30, 2022 | -89.20% |
| June 30, 2022 | -107.8% |
| March 31, 2022 | -126.1% |
| December 31, 2021 | -108.4% |
| September 30, 2021 | -108.7% |
| June 30, 2021 | -114.3% |
| March 31, 2021 | -121.5% |
| Date | Value |
|---|---|
| December 31, 2020 | -116.8% |
| September 30, 2020 | -74.98% |
| June 30, 2020 | -133.0% |
| March 31, 2020 | -164.6% |
| December 31, 2019 | -324.2% |
| September 30, 2019 | -198.1% |
| June 30, 2019 | -205.3% |
| March 31, 2019 | -191.3% |
| December 31, 2018 | -197.0% |
| September 30, 2018 | -235.5% |
| June 30, 2018 | -269.4% |
| March 31, 2018 | -273.6% |
| December 31, 2017 | -392.7% |
| September 30, 2017 | -490.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-324.2%
Minimum
Dec 2019
-60.15%
Maximum
Dec 2023
-113.1%
Average
-107.8%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| ResMed Inc | 25.43% |
| RxSight Inc | -17.42% |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | -12.89% |
| Catheter Precision Inc | -4.54K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.70% |
| Return on Assets | -30.09% |
| Return on Invested Capital | -37.70% |
| Gross Profit Margin (Quarterly) | 43.30% |
| Operating Margin (Quarterly) | -54.00% |
| Return on Net Operating Assets | -55.88% |